DE3586420D1 - Verwendung von dihydropyridinen zur behandlung und praevention von arteriosklerose. - Google Patents
Verwendung von dihydropyridinen zur behandlung und praevention von arteriosklerose.Info
- Publication number
- DE3586420D1 DE3586420D1 DE8585115605T DE3586420T DE3586420D1 DE 3586420 D1 DE3586420 D1 DE 3586420D1 DE 8585115605 T DE8585115605 T DE 8585115605T DE 3586420 T DE3586420 T DE 3586420T DE 3586420 D1 DE3586420 D1 DE 3586420D1
- Authority
- DE
- Germany
- Prior art keywords
- dihydropyridines
- arteriosclerosis
- prevention
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Urology & Nephrology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB848431119A GB8431119D0 (en) | 1984-12-10 | 1984-12-10 | Anti-arteriosclerotic composition |
Publications (2)
Publication Number | Publication Date |
---|---|
DE3586420D1 true DE3586420D1 (de) | 1992-09-03 |
DE3586420T2 DE3586420T2 (de) | 1993-01-07 |
Family
ID=10570949
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE8585115605T Expired - Fee Related DE3586420T2 (de) | 1984-12-10 | 1985-12-07 | Verwendung von dihydropyridinen zur behandlung und praevention von arteriosklerose. |
Country Status (5)
Country | Link |
---|---|
US (1) | US4859688A (de) |
EP (1) | EP0185283B1 (de) |
JP (1) | JPS61155327A (de) |
DE (1) | DE3586420T2 (de) |
GB (1) | GB8431119D0 (de) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4782070A (en) * | 1986-07-01 | 1988-11-01 | Fujisawa Pharmaceutical Co., Ltd. | Cerebral dysfunction therapeutic agent, which comprises a dihydropyridine compound |
US5045553A (en) * | 1987-06-24 | 1991-09-03 | Fujisawa Pharmaceutical Company, Ltd. | Pharmaceutical composition for percutaneous drug absorption and percutaneous drug absorption promoter |
ES2070307T3 (es) * | 1990-07-04 | 1995-06-01 | Marcin Krotkiewski | Una preparacion para el tratamiento de la hipertension. |
IT1244728B (it) * | 1991-02-13 | 1994-08-08 | Glaxo Spa | Impiego medicamentoso di derivati diidropiridinici |
DK1628663T3 (da) * | 2003-05-15 | 2010-03-08 | Roskamp Res Llc | Fremgangsmåde til fremstilling af medikamenter til reduktion af amyloid-aflejring, amyloid-neurotoksicitet og mikrogliose |
US20100093810A1 (en) * | 2007-10-05 | 2010-04-15 | Alzheimer's Institute Of America, Inc. | Pharmaceutical Compositions for Reducing Amyloid Deposition, Amyloid Neurotoxicity, and Microgliosis |
DK2214666T3 (da) * | 2007-10-05 | 2014-01-27 | Alzheimer S Inst Of America Inc | Fremgangsmåde til reducering af amyloid-afsætning, amyloid-neurotoksicitet og mikrogliose med (-)-nilvadipin-enantiomer |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4338322A (en) * | 1975-07-02 | 1982-07-06 | Fujisawa Pharmaceutical Co., Ltd. | 1,4-Dihydropyridine derivatives, pharmaceutical compositions containing same and methods of effecting vasodilation using same |
US4150119A (en) * | 1976-10-22 | 1979-04-17 | Jesus Emilio Lince Isaza | Method for treatment of vascular disease |
US4307103A (en) * | 1978-09-08 | 1981-12-22 | Fujisawa Pharmaceutical Co., Ltd. | Dihydropyridine derivative, processes for preparation thereof and pharmaceutical composition comprising the same |
CA1117117A (en) * | 1978-10-10 | 1982-01-26 | Fujisawa Pharmaceutical Co., Ltd. | 2-methyl-dihydropyridine compound, processes for preparation thereof and pharmaceutical composition comprising the same |
US4442100A (en) * | 1979-12-11 | 1984-04-10 | Bayer Aktiengesellschaft | Substituted 2-amino-3,4-dihydropyridine derivatives, their production and their medicinal use |
DE3222367A1 (de) * | 1982-06-15 | 1983-12-15 | Bayer Ag, 5090 Leverkusen | Verwendung von 1,4-dihydropyridinen in antiarteriosklerotika und deren herstellung |
JPS597163A (ja) * | 1982-07-02 | 1984-01-14 | Yamanouchi Pharmaceut Co Ltd | 抗動脈硬化剤 |
DE3307422A1 (de) * | 1983-03-03 | 1984-09-06 | Bayer Ag, 5090 Leverkusen | Fluessigzubereitungen von dihydropyridinen, ein verfahren zu ihrer herstellung, sowie ihre verwendung bei der bekaempfung von erkrankungen |
EP0125803A3 (de) * | 1983-04-27 | 1987-01-21 | FISONS plc | Pharmazeutisch aktive Dihydropyridine |
-
1984
- 1984-12-10 GB GB848431119A patent/GB8431119D0/en active Pending
-
1985
- 1985-12-07 DE DE8585115605T patent/DE3586420T2/de not_active Expired - Fee Related
- 1985-12-07 EP EP85115605A patent/EP0185283B1/de not_active Expired - Lifetime
- 1985-12-09 JP JP60277284A patent/JPS61155327A/ja active Granted
-
1987
- 1987-03-30 US US07/031,746 patent/US4859688A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
GB8431119D0 (en) | 1985-01-16 |
EP0185283A3 (en) | 1989-07-19 |
JPS61155327A (ja) | 1986-07-15 |
DE3586420T2 (de) | 1993-01-07 |
JPH0529209B2 (de) | 1993-04-28 |
US4859688A (en) | 1989-08-22 |
EP0185283B1 (de) | 1992-07-29 |
EP0185283A2 (de) | 1986-06-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3579113D1 (de) | Zusammensetzungen zur milderung, behandlung und bestimmungung von arthritschen krankheiten und aehnlichen zustaenden. | |
DE68920775D1 (de) | Behandlung von faserigen Materialien. | |
DE69224080D1 (de) | Verwendung von nsaid zur behandlung von demenz | |
DE68929554D1 (de) | Piperazinyl-substituierte Phenylpyrimidinderivative zur Behandlung oder Vorbeugung von ZNS Erkrankungen | |
ATE31670T1 (de) | Verfahren zur behandlung von verpackungsmaterial und das dementsprechend behandelte material. | |
DE3780972D1 (de) | Verwendung von spezifischen n-methyl-d-aspartat-rezeptor-antagonisten zur praevention und behandlung von neurodegeneration. | |
DE69212620D1 (de) | Verwendung von Glycosaminoglycanen zur Behandlung von diabetischer Nephropathie und diabetischer Neuropathie | |
DE69115921D1 (de) | Verfahren zur behandlung und verwendung von abfallstoffen | |
DE3667605D1 (de) | Windel zur verhuetung von wundliegen. | |
DE3888056D1 (de) | Oxadiazolyl-azabicycloheptane zur Behandlung von seniler Demenz. | |
DE3782028D1 (de) | Verwendung von ketonderivaten zur behandlung von bewusstseinsstoerungen. | |
DE3850433D1 (de) | Allergiebehandlung und Zusammensetzung dafür. | |
DE68911776D1 (de) | Konjugierte Oxybutenolide zur Behandlung von Ulcera. | |
DE3586420D1 (de) | Verwendung von dihydropyridinen zur behandlung und praevention von arteriosklerose. | |
DE3686019D1 (de) | Die verwendung von nitrofurantoin zur behandlung und verhuetung von magen-darmkrankheiten. | |
DE68909068D1 (de) | Behandlung von anorganischen Baumaterialien. | |
DE69004301D1 (de) | Mischung zur Behandlung der von exokrinen Insuffizienz der Bauchspeicheldrüse und die Verwendung der genannten Mischung. | |
DE68907569D1 (de) | Mittel zur behandlung oder vorbeugung von aids. | |
DE3785555D1 (de) | Verwendung von guaifenesin zur behandlung urologischer beschwerden. | |
DE68908404D1 (de) | Lang haltende zusammensetzung von propafenon und chinidin zur behandlung des zustandes des herzens. | |
DE68917616D1 (de) | Demulgator-Zusammensetzungen und Herstellungsmethode und Verwendung. | |
DE68913779D1 (de) | D-Amidase und Verfahren zur Herstellung von D-alpha-Alanin und/oder L-alpha-Alaninamid. | |
DE69715878D1 (de) | Formulierung zur behandlung und/oder vorbeugung von dementia | |
ATE136463T1 (de) | Verwendung von 1,2,3,4-tetrahydroacridinen zur behandlung von aids, sowie verbindungen | |
DE68929177D1 (de) | Verwendung von Dihydropyridinen zur Vorbeugung und Behandlung cerebraler Durchblutungsstörungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |